10 employees
Primo aims at precision medicine and help the development of radioligand theranostics (RLT).
2023
$2.5M
from 2 investors over 2 rounds
Primo Biotechnology 普瑞默生技 raised $2.5M on January 10, 2023
Investors: AVA Angels